se of CA125,HE4 and Risk of ovarian malignancy(ROMA) index in ovarian cancer
Not Applicable
- Conditions
- Health Condition 1: N838- Other noninflammatory disorders ofovary, fallopian tube and broad ligament
- Registration Number
- CTRI/2020/09/027922
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of any age group with complex adnexal mass
Exclusion Criteria
1. Pregnant females
2. Known cases of genital malignancy
3. Previously treated for ovarian malignancy
4. Known cases of endometriosis or pelvic
tuberculosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To independently evaluate CA-125, HE4 and the combination of HE4 and CA125 using Risk of Ovarian Malignancy Algorithm (ROMA) for the diagnosis of ovarian cancerTimepoint: At enrolment
- Secondary Outcome Measures
Name Time Method 1. To see association of the tests with the type of histology of ovarian cancer <br/ ><br>2. To see association of the tests with the stage of the ovarian cancerTimepoint: at enrollment , after biopsy or imaging and postoperatively